Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline.
Purpose: To provide the clinical recommendations for the administration of intravitreal anti-vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular diseases including diabetic macular edema, neovascular age-related macular degeneration, myopic choroidal neovascula...
| Publicado en: | Journal of Ophthalmic & Vision Research Vol. 13; no. 2; pp. 158 - 170 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | practice guidelines tables/charts Journal Article |
| Publicado: |
Knowledge E DMCC
Apr-Jun2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=129131375&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 129131375 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 20082010 AY5S jtl: Journal of Ophthalmic & Vision Research issn: 20082010 maglogo: N pubinfo: dt: Apr-Jun2018 vid: 13 iid: 2 pid: 35682 pub: Knowledge E DMCC artinfo: ui: 129131375 129131375 129131375 10.4103/jovr.jovr_50_18 129131375 ppf: 158 ppct: 12 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline. aug: au: Nikkhah, Homayoun Karimi, Saeed Ahmadieh, Hamid Azarmina, Mohsen Abrishami, Majid Ahoor, Hossein Alizadeh, Yousef Behboudi, Hasan Daftarian, Narsis Dehghan, Mohammad Entezari, Morteza Farrahi, Fereydoun Ghanbari, Heshmatollah Falavarjani, Khalil Javadi, Mohammad Karkhaneh, Reza Moradian, Siamak Manaviat, Masoud Mehryar, Morsal Nourinia, Ramin affil: Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran sug: subj: Bevacizumab Administration and Dosage Administration, Intraocular Eye Diseases Drug Therapy Vascular Diseases Drug Therapy Macular Degeneration Drug Therapy Neovascularization, Pathologic Drug Therapy Retinal Vein Occlusion Drug Therapy Retinal Diseases Drug Therapy Diabetic Retinopathy Drug Therapy Bevacizumab Therapeutic Use Vascular Endothelial Growth Factors Decision Making, Clinical Medical Practice, Evidence-Based Policy Making Injections Eye Care ab: Purpose: To provide the clinical recommendations for the administration of intravitreal anti-vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular diseases including diabetic macular edema, neovascular age-related macular degeneration, myopic choroidal neovascularization, retinal vein occlusion and central serous chorioretinopathy. Methods: Twenty clinical questions were developed by the guideline technical committee. Relevant websites and databases were searched to find out the pertinent clinical practice guidelines to answer the questions. The technical committee provided possible answers (scenarios) according to the available evidences for each question. All scenarios along with their levels of evidence and the supported articles were sent to the experts for external review. If the experts did not agree on any of the scenarios for one particular clinical question, the technical committee reviewed all scenarios and their pertinent evidences and made the necessary decision. After that, the experts were asked to score them again. All confirmed scenarios were gathered as the final recommendations. Results: All the experts agreed on at least one of the scenarios. The technical committee extracted the agreed scenario for each clinical question as the final recommendation. Finally, 56 recommendations were developed for the procedure of intravitreal anti-VEGF injection and their applications in the management of ocular vascular diseases. Conclusion: The implementation of this guideline can standardize the management of the common ocular vascular diseases by intravitreal injection of anti-VEGF agents. It can lead to better policy-making and evidence-based clinical decision by ophthalmologists and optimal evidence based eye care for patients. pubtype: Academic Journal doctype: practice guidelines tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|